Home
|
Contact Us
|
Bookmark
HEPATITIS
HBV
HCV
HDV
CIRRHOSIS
HEPATIC ENCEPHALOPATHY (HE)
HEPATORENAL SYNDROME (HRS)
PRIMARY BILIARY CHOLANGITIS (PBC)
THROMBOCYTOPENIA
NASH
HCC
LiverQ Academy
About CLDF
Board of Trustees
Board of Advisors/Faculty
2020 GI Fellow Board of Advisors
CLDF Committees
Centers of Educational Expertise
Live CME Events
Webcasts
Slide Library
Abstract Library
CLDF 2019 Year in Review
Conference Highlights
Public Health
Available Topics
11-25-2020
Patients cured of HCV still at high liver-cancer risk
09-12-2018
Bayer adds label warning to stomach relief drops
04-24-2018
REFILE-Almost 300 million worldwide may be infected with HBV
04-03-2018
Almost 300 million worldwide may be infected with HBV
12-05-2014
Pakistani blood transfusions spreading hepatitis, HIV: official
11-28-2014
Many IBD patients don't get hepatitis B vaccine: US study
11-28-2014
REFILE-Many IBD patients don't get hepatitis B vaccine: US study
11-27-2014
Colon neoplasia more common in UC-PSC than Crohn's-PSC
11-26-2014
Celiac disease showing up in many forms and at all ages
11-24-2014
Vitamin D, mortality may be linked in non-cirrhotic alcoholics
11-21-2014
Most heavy drinkers are not alcoholics, U.S. study finds
11-20-2014
France pegs Gilead hepatitis C drug at "lowest price in Europe"
11-11-2014
Sustained viral response to HCV meds bodes well for long-term survival
11-11-2014
Gilead hepatitis C drug highly effective in cirrhosis patients
11-10-2014
Merck four-week hep C regimen with Gilead's Sovaldi comes up short
11-06-2014
High-risk coronary plaque linked to common liver disease
10-27-2014
Maintenance opioid agonists protect against HCV in injection drug users
10-21-2014
Giving pricey hepatitis drug to prisoners may be financially wise
10-21-2014
REFILE-Giving pricey hepatitis drug to prisoners may be financially wise
10-15-2014
Unsaturated fats might offset heart risk from weight gain
09-15-2014
Gilead signs hepatitis C pact to cut drug cost for poor
09-03-2014
Even if you build a toilet, they may not come - water expert
09-01-2014
Increasing rates of acute hepatitis C infection among young Americans
08-28-2014
U.S. infant vaccination rates high, timeliness a concern -CDC
08-14-2014
Rifamycin-containing regimens may be preferable in latent tuberculosis
08-04-2014
U.S. hepatitis C burden may ease in coming decades: study
07-30-2014
Novartis drug clears malaria parasite in phase II study
05-08-2014
One billion people still defecate in public despite health risks-UN
04-18-2014
West African Ebola outbreak caused by new strain of disease: study
04-09-2014
WHO joins clamor to make new hepatitis C pills affordable
04-08-2014
Gilead aims to license hepatitis C drug to 3-4 Indian firms
04-02-2014
Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
04-02-2014
Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
03-13-2014
NY hospital warns patients of possible HIV, hepatitis exposure
03-04-2014
Passion for vodka kills Russian men in their 50s
01-07-2014
Most U.S. doctors fail to discuss alcohol with patients
01-03-2014
China says child deaths not linked to hepatitis vaccine
12-27-2013
Single injection of liposomal amphotericin cures visceral leishmaniasis
12-23-2013
China investigates after vaccine suspected in seven deaths
12-16-2013
Fight for cheap drugs shifts from AIDS to new hepatitis pills
HEPATITIS
HBV
HCV
HDV
HCC
Slide Library
Abstract Library
HE
Webcasts
Slide Library
Abstract Library
HRS
Webcasts
Slide Library
Abstract Library
NASH
Webcasts
Slide Library
Abstract Library
PBC
Webcasts
Slide Library
Abstract Library
THROMBOCYTOPENIA
Webcasts
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2021 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation
terms of use
and
privacy statement
.